PCX.F
Paychex, Inc.
FrankfurtEUREQUITY
Technology
DELAYED
Last price
104.26
■ 0.00 (0.00%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
104.26
Day high
105.00
Day low
104.26
Volume
150
Market cap
$37.08B
P/E (TTM)
24.94
52W range
72.47 – 119.86
Trailing performance
Returnvs SPY
1W
-1.60%
-0.2%
1M
+8.34%
+4.6%
3M
+28.92%
+25.8%
6M
+40.21%
+29.1%
YTD
+8.03%
-4.3%
1Y
-12.03%
-32.0%
3Y
-7.24%
-81.4%
5Y
+11.56%
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on PCX.F open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
36.85M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Jul 20, 26 | SCHRADER ROBERT L. Chief Financial Officer |
SELL | 2.60K | $299.23K | Direct |
| Jul 17, 26 | SIMMONS CHRISTOPHER C Officer and Treasurer |
SELL | 2.62K | $303.13K | Direct |
| Jul 17, 26 | MUCCI MARTIN Chairman of the Board |
STOCK | 9.31K | $1.06M | Direct |
| Jul 15, 26 | BERGSTROM RYAN NORMAN Officer |
STOCK | 3.41K | $0 | Direct |
| Jul 15, 26 | SIMMONS CHRISTOPHER C Officer and Treasurer |
STOCK | 1.82K | $0 | Direct |
| Jul 15, 26 | ARGIROPOULOS MASON Officer |
STOCK | 2.18K | $0 | Direct |
| Jul 15, 26 | PARODI CHAD C Officer |
STOCK | 2.73K | $0 | Direct |
| Jul 15, 26 | SCHRADER ROBERT L. Chief Financial Officer |
STOCK | 4.36K | $0 | Direct |
| Jul 15, 26 | ANTE ADAM BROOKS Officer |
STOCK | 3.41K | $0 | Direct |
| Jul 15, 26 | GIBSON JOHN B JR Chief Executive Officer |
STOCK | 14.32K | $0 | Direct |
| Jul 14, 26 | MUCCI MARTIN Chairman of the Board |
CONVERSION | 214.48K | $12.28M | Direct |
| Jul 14, 26 | MUCCI MARTIN Chairman of the Board |
SELL | 25.00K | $2.75M | Direct |
| Jun 26, 26 | TUCCI JOSEPH M Director |
CONVERSION | 10.22K | $619.23K | Direct |
| Jun 26, 26 | TUCCI JOSEPH M Director |
SELL | 3.91K | $383.86K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
ANTE ADAM BROOKS |
Officer | 55.98K | Stock Award(Grant) |
BERGSTROM RYAN NORMAN |
Officer | 44.69K | Stock Award(Grant) |
BOTTINI MARK ANTHONY |
Officer | 81.06K | Conversion of Exercise of derivative security |
DOODY JOSEPH G |
Director | — | Purchase |
GIBSON JOHN B JR |
Chief Executive Officer | 81.37K | Stock Award(Grant) |
GIOJA MICHAEL E |
Officer | 23.98K | Conversion of Exercise of derivative security |
GOLISANO B THOMAS |
Beneficial Owner of more than 10% of a Class of Security | — | Stock Gift |
MUCCI MARTIN |
Chairman of the Board | 434.89K | Stock Gift |
TUCCI JOSEPH M |
Director | 67.36K | Conversion of Exercise of derivative security |
VELLI JOSEPH M |
Director | 89.56K | Conversion of Exercise of derivative security |
Fundamentals
Market cap$37.08B
Enterprise value$40.57B
Revenue (TTM)$3.97B
Gross profit$2.67B
EBITDA$1.61B
Net income—
EPS (TTM)$4.18
Free cash flow—
Total cash$1.14B
Total debt$4.63B
Book value / share$9.07
Shares outstanding355.68M
Float—
Short % of float—
Dividend yield4.01%
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E24.94
Forward P/E28.96
PEG ratio2.14
Price / sales—
Price / book11.50
EV / revenue10.22
EV / EBITDA25.23
Gross margin67.20%
Operating margin38.32%
Profit margin26.63%
Return on equity—
Return on assets—
Debt / equity123.97
Current ratio1.15
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Total revenue | $6.51B | $5.57B | $5.28B | $5.01B | +16.9% |
| Operating revenue | $6.30B | $5.41B | $5.13B | $4.91B | +16.5% |
| Cost of revenue | $1.67B | $1.54B | $1.48B | $1.45B | +8.7% |
| Gross profit | $4.84B | $4.03B | $3.80B | $3.55B | +20.0% |
| Selling, general & admin | $2.33B | $1.82B | $1.62B | $1.52B | +27.6% |
| Total operating expense | $2.33B | $1.82B | $1.62B | $1.52B | +27.6% |
| Operating income | $2.51B | $2.21B | $2.17B | $2.03B | +13.7% |
| Net interest income | -$206.10M | -$32.60M | $45.40M | $12.40M | -532.2% |
| Pre-tax income | $2.31B | $2.18B | $2.22B | $2.05B | +6.2% |
| Tax provision | $550.80M | $518.60M | $527.60M | $490.90M | +6.2% |
| Net income | $1.76B | $1.66B | $1.69B | $1.56B | +6.2% |
| Net income to common | $1.76B | $1.66B | $1.69B | $1.56B | +6.2% |
| Basic EPS | 4.90 | 4.60 | 4.69 | 4.32 | +6.5% |
| Diluted EPS | 4.89 | 4.58 | 4.67 | 4.30 | +6.8% |
| EBIT | $2.58B | $2.28B | $2.26B | $2.08B | +13.1% |
| EBITDA | $3.02B | $2.49B | $2.43B | $2.26B | +21.4% |
| Basic shares | 358.90M | 360.20M | 360.30M | 360.40M | -0.4% |
| Diluted shares | 360.00M | 362.00M | 362.10M | 362.30M | -0.6% |
| Line item | 2026 | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.09B | $1.63B | $1.47B | $1.22B | — | -33.2% |
| Cash & short-term investments | $1.12B | $1.66B | $1.50B | $1.60B | — | -32.4% |
| Accounts receivable | $1.51B | $1.33B | $1.06B | $873.30M | — | +13.3% |
| Total current assets | $8.61B | $8.92B | $7.25B | $7.53B | — | -3.4% |
| Property, plant & equipment | $652.80M | $575.30M | $458.60M | $457.80M | — | +13.5% |
| Goodwill & intangibles | $6.21B | $6.46B | $2.08B | $2.02B | — | -3.9% |
| Total assets | $16.17B | $16.56B | $10.38B | $10.55B | — | -2.4% |
| Total current liabilities | $6.84B | $6.96B | $5.31B | $5.81B | — | -1.7% |
| Current debt | — | $418.40M | $18.70M | $10.20M | $8.70M | — |
| Long-term debt | $4.56B | $4.55B | $798.60M | $798.20M | — | +0.2% |
| Total debt | $4.61B | $5.02B | $866.30M | $865.70M | — | -8.2% |
| Total liabilities | $12.44B | $12.44B | $6.58B | $7.05B | — | +0.0% |
| Retained earnings | $1.81B | $2.28B | $2.21B | $2.02B | — | -20.7% |
| Shareholder equity | $3.74B | $4.13B | $3.80B | $3.49B | — | -9.5% |
| Working capital | $1.77B | $1.96B | $1.94B | $1.72B | — | -9.6% |
| Net tangible assets | -$2.48B | -$2.33B | $1.72B | $1.47B | — | -6.1% |
| Shares issued | 355.60M | 360.50M | 360.10M | 360.50M | — | -1.4% |
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Net income | $1.76B | $1.66B | $1.69B | $1.56B | +6.2% |
| Depreciation & amortisation | $442.60M | $209.50M | $176.50M | $176.60M | +111.3% |
| Stock-based compensation | $96.10M | $111.80M | $61.10M | $62.60M | -14.0% |
| Change in working capital | -$124.10M | -$330.90M | -$280.40M | -$312.40M | +62.5% |
| Operating cash flow | $2.56B | $1.90B | $1.90B | $1.71B | +34.5% |
| Capital expenditure | -$234.90M | -$191.80M | -$161.40M | -$143.00M | -22.5% |
| Investing cash flow | -$1.15B | -$3.36B | -$260.90M | $211.70M | +65.7% |
| Share buybacks | -$611.00M | -$104.50M | -$169.20M | $0 | -484.7% |
| Dividends paid | -$1.59B | -$1.45B | -$1.32B | -$1.18B | -9.7% |
| Financing cash flow | -$2.65B | $2.29B | -$1.87B | -$711.40M | -215.7% |
| Free cash flow | $2.32B | $1.71B | $1.74B | $1.56B | +35.8% |
| End cash position | $1.48B | $2.73B | $1.90B | $2.13B | -45.7% |
| Line item | 2026-05-31 | 2026-02-28 | 2025-11-30 | 2025-08-31 | 2025-05-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $1.61B | $1.81B | $1.56B | $1.54B | $1.43B | -11.2% |
| Operating revenue | $1.55B | $1.75B | $1.50B | $1.49B | $1.38B | -11.3% |
| Cost of revenue | $417.30M | $431.20M | $412.20M | $413.80M | $393.90M | -3.2% |
| Gross profit | $1.19B | $1.38B | $1.15B | $1.13B | $1.03B | -13.8% |
| Selling, general & admin | $583.50M | $585.70M | $573.50M | $584.30M | $602.30M | -0.4% |
| Total operating expense | $583.50M | $585.70M | $573.50M | $584.30M | $602.30M | -0.4% |
| Operating income | $604.70M | $792.00M | $571.90M | $541.90M | $431.10M | -23.6% |
| Net interest income | -$51.70M | -$52.90M | -$52.00M | -$49.50M | -$43.20M | +2.3% |
| Pre-tax income | $554.20M | $739.00M | $520.20M | $497.50M | $389.30M | -25.0% |
| Tax provision | $133.60M | $178.70M | $124.80M | $113.70M | $92.10M | -25.2% |
| Net income | $420.60M | $560.30M | $395.40M | $383.80M | $297.20M | -24.9% |
| Net income to common | $420.60M | $560.30M | $395.40M | $383.80M | $297.20M | -24.9% |
| Basic EPS | 1.18 | 1.56 | 1.10 | 1.07 | 0.82 | -24.4% |
| Diluted EPS | 1.17 | 1.56 | 1.10 | 1.06 | 0.82 | -25.0% |
| EBIT | $618.90M | $807.10M | $588.70M | $565.70M | $453.00M | -23.3% |
| EBITDA | $732.10M | $918.10M | $697.80M | $675.00M | $538.70M | -20.3% |
| Basic shares | 357.60M | 358.70M | 359.40M | 360.10M | 360.30M | -0.3% |
| Diluted shares | 358.20M | 359.50M | 360.40M | 361.90M | 362.30M | -0.4% |
| Line item | 2026-05-31 | 2026-02-28 | 2025-11-30 | 2025-08-31 | 2025-05-31 | 2025-02-28 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $1.09B | $1.74B | $1.49B | $809.00M | $1.63B | — | -37.5% |
| Cash & short-term investments | $1.12B | $1.78B | $1.52B | $1.67B | $1.66B | — | -36.8% |
| Accounts receivable | $1.51B | $1.44B | $1.36B | $1.36B | $1.33B | — | +5.1% |
| Total current assets | $8.61B | $9.93B | $8.91B | $9.04B | $8.92B | — | -13.2% |
| Property, plant & equipment | $652.80M | $639.00M | $631.30M | $589.60M | $575.30M | — | +2.2% |
| Goodwill & intangibles | $6.21B | $6.27B | $6.34B | $6.41B | $6.46B | — | -1.0% |
| Total assets | $16.17B | $17.51B | $16.52B | $16.66B | $16.56B | — | -7.6% |
| Total current liabilities | $6.84B | $7.88B | $7.04B | $7.13B | $6.96B | — | -13.2% |
| Current debt | — | $400.00M | $418.10M | $418.40M | $418.40M | $17.60M | — |
| Long-term debt | $4.56B | $4.55B | $4.55B | $4.55B | $4.55B | — | +0.0% |
| Total debt | $4.61B | $5.01B | $5.04B | $5.02B | $5.02B | — | -8.1% |
| Total liabilities | $12.44B | $13.50B | $12.64B | $12.69B | $12.44B | — | -7.8% |
| Retained earnings | $1.81B | $2.05B | $1.95B | $2.07B | $2.28B | — | -11.8% |
| Shareholder equity | $3.74B | $4.01B | $3.88B | $3.97B | $4.13B | — | -6.9% |
| Working capital | $1.77B | $2.05B | $1.87B | $1.91B | $1.96B | — | -13.5% |
| Net tangible assets | -$2.48B | -$2.26B | -$2.46B | -$2.44B | -$2.33B | — | -9.5% |
| Shares issued | 355.60M | 358.29M | 358.97M | 359.89M | 360.50M | — | -0.8% |
| Line item | 2026-05-31 | 2026-02-28 | 2025-11-30 | 2025-08-31 | 2025-05-31 | YoY |
|---|---|---|---|---|---|---|
| Net income | $420.60M | $560.30M | $395.40M | $383.80M | $297.20M | -24.9% |
| Depreciation & amortisation | $113.20M | $111.00M | $109.10M | $109.30M | $85.70M | +2.0% |
| Stock-based compensation | $20.70M | $23.10M | $25.50M | $26.80M | $61.30M | -10.4% |
| Change in working capital | -$56.00M | $18.50M | -$153.10M | $66.50M | -$189.20M | -402.7% |
| Operating cash flow | $580.90M | $812.50M | $444.90M | $718.40M | $343.80M | -28.5% |
| Capital expenditure | -$65.90M | -$51.00M | -$62.10M | -$55.90M | -$60.50M | -29.2% |
| Investing cash flow | -$227.40M | $1.40M | $376.30M | -$1.30B | -$3.08B | -16,342.9% |
| Share buybacks | -$249.40M | -$75.00M | -$126.50M | -$160.10M | $0 | -232.5% |
| Dividends paid | -$424.60M | -$388.00M | -$387.90M | -$389.10M | -$389.30M | -9.4% |
| Financing cash flow | -$1.79B | $235.30M | -$582.40M | -$515.40M | $3.07B | -861.3% |
| Free cash flow | $515.00M | $761.50M | $382.80M | $662.50M | $283.30M | -32.4% |
| End cash position | $1.48B | $2.92B | $1.87B | $1.63B | $2.73B | -49.2% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $1.63B | +5.6% |
| Next quarter | — | — | $1.64B | +5.2% |
| Current year | — | — | $6.88B | +5.6% |
| Next year | — | — | $7.24B | +5.2% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders10.36%
Held by institutions85.68%
Institutions holding2.00K
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
103.88
+0.37% from price
SMA 20
103.06
+1.17% from price
SMA 50
96.02
+8.58% from price
SMA 100
87.91
+18.59% from price
SMA 200
88.30
+18.07% from price
EMA 12
103.42
+0.81% from price
EMA 26
101.18
+3.04% from price
EMA 50
97.11
+7.36% from price
RSI (14)
57.7
Neutral
MACD (12,26,9)
2.23
Hist -0.33
ATR (14)
1.93
1.86% of price
Realised vol 30D
38.5%
Annualised
Bollinger upper
107.22
20, 2σ
Bollinger lower
98.90
20, 2σ
50 / 200 cross
Golden
96.02 vs 88.30
Trend bias
Above 200
+18.07%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
-0.08
Less volatile than market
Correlation to SPY
-0.03
Largely independent
Realised vol 30D
38.5%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-38.9%
Peak to trough
Max drawdown 5Y
-50.0%
Peak to trough
ATR 14
1.93
1.86% of price
Beta (reported)
—
5Y monthly, from filing
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 13, 26 | Jefferies | MAINTAINED | Hold | Hold |
| Jul 30, 26 | Citigroup | MAINTAINED | Buy | Buy |
| Jul 22, 26 | UBS | MAINTAINED | Neutral | Neutral |
| Jun 30, 26 | Morgan Stanley | MAINTAINED | Equal-Weight | Equal-Weight |
| Jun 25, 26 | UBS | MAINTAINED | Neutral | Neutral |
| Jun 25, 26 | JP Morgan | MAINTAINED | Underweight | Underweight |
| Jun 17, 26 | Stifel | MAINTAINED | Hold | Hold |
| Jun 15, 26 | Citigroup | UPGRADE | Neutral | Buy |
| Jun 8, 26 | TD Cowen | MAINTAINED | Hold | Hold |
| Apr 13, 26 | UBS | MAINTAINED | Neutral | Neutral |
| Mar 26, 26 | JP Morgan | MAINTAINED | Underweight | Underweight |
| Mar 26, 26 | Citigroup | MAINTAINED | Neutral | Neutral |
Dividends & splits
Forward rate$4.18 / yr
Forward yield4.01%
5-year avg yield2.85%
Payout ratio90.59%
Ex-dividend dateJul 28, 2026
Next pay date—
Last split—
Split date—
Headlines
TME Pharma provides update on its activities
GlobeNewswire · 9m ago
American Chemical Society Names Syngenta's Camilla Corsi the 2026 Winner of Prestigious International Award for Research in Agrochemicals
Business Wire · 14m ago
Valerio Therapeutics Announces Signing of Definitive Agreements for the Acquisition of Etherna Immunotherapies, Building a Leading Platform in Targeted RNA, and €40.25 Million PIPE Financing From New and Existing Investors
Business Wire · 14m ago
Board Update
GlobeNewswire · 14m ago
Aegon implements EUR 150 million increase in share buyback program
GlobeNewswire · 14m ago
TOMY's "TOMICA XROSS RESCUE" Diorama-based Short Animation Series to Begin Streaming Aug. 26, 2026
PR Newswire · 14m ago
Holding(s) in Company
GlobeNewswire · 14m ago
Summary of AB KN Energies webinar
GlobeNewswire · 14m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.